Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Multiple drugs

Multiple drugs Reactions 1704, p262 - 2 Jun 2018 Various toxicities: 10 case reports In a single-center, retrospective study of an 11 patients, 10 patients (4 women and 6 men) aged 37 66 years were described, who developed thrombotic thrombocytopenic purpura (TTP), posterior reversible encephalopathy syndrome (PRES), increased serum creatinine level, acute kidney injury (AKI) or neutropenia during treatment with ciclosporin, everolimus, prednisone or tacrolimus [routes, dosages and time to reactions onsets not stated; not all outcomes stated]. The patients underwent bilateral sequential lung transplantation (8 patients) or single lung transplantation (2 patients) for interstitial lung disease, chronic obstructive pulmonary disease, graft-versus-host disease or idiopathic pulmonary fibrosis. The patient’s baseline immunosuppressive regimen included basiliximab (n=2) or alemtuzumab (n=8) induction along with tacrolimus, ciclosporin, everolimus, prednisone, mycophenolate, mycophenolate mofetil or hydrocortisone. The treatment with standard prophylaxis regimen was also initiated, which included unspecified mold- active triazole antifungals, valganciclovir for prevention of cytomegalovirus and cotrimoxazole for pneumocystis prophylaxis. Eventually, the patients developed PRES due to tacrolimus (n=1), TTP due to tacrolimus and ciclosporin (n=1), TTP and PRES due to tacrolimus and ciclosporin (n=1), TTP due to tacrolimus (n=1), PRES due to ciclosporin (n=2), TTP due to ciclosporin (n=1), increased serum creatinine due to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Multiple drugs

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018

Multiple drugs

Abstract

Reactions 1704, p262 - 2 Jun 2018 Various toxicities: 10 case reports In a single-center, retrospective study of an 11 patients, 10 patients (4 women and 6 men) aged 37 66 years were described, who developed thrombotic thrombocytopenic purpura (TTP), posterior reversible encephalopathy syndrome (PRES), increased serum creatinine level, acute kidney injury (AKI) or neutropenia during treatment with ciclosporin, everolimus, prednisone or tacrolimus [routes, dosages and time to reactions onsets...
Loading next page...
 
/lp/springer_journal/multiple-drugs-fF9X3yYOhq

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-018-46905-6
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p262 - 2 Jun 2018 Various toxicities: 10 case reports In a single-center, retrospective study of an 11 patients, 10 patients (4 women and 6 men) aged 37 66 years were described, who developed thrombotic thrombocytopenic purpura (TTP), posterior reversible encephalopathy syndrome (PRES), increased serum creatinine level, acute kidney injury (AKI) or neutropenia during treatment with ciclosporin, everolimus, prednisone or tacrolimus [routes, dosages and time to reactions onsets not stated; not all outcomes stated]. The patients underwent bilateral sequential lung transplantation (8 patients) or single lung transplantation (2 patients) for interstitial lung disease, chronic obstructive pulmonary disease, graft-versus-host disease or idiopathic pulmonary fibrosis. The patient’s baseline immunosuppressive regimen included basiliximab (n=2) or alemtuzumab (n=8) induction along with tacrolimus, ciclosporin, everolimus, prednisone, mycophenolate, mycophenolate mofetil or hydrocortisone. The treatment with standard prophylaxis regimen was also initiated, which included unspecified mold- active triazole antifungals, valganciclovir for prevention of cytomegalovirus and cotrimoxazole for pneumocystis prophylaxis. Eventually, the patients developed PRES due to tacrolimus (n=1), TTP due to tacrolimus and ciclosporin (n=1), TTP and PRES due to tacrolimus and ciclosporin (n=1), TTP due to tacrolimus (n=1), PRES due to ciclosporin (n=2), TTP due to ciclosporin (n=1), increased serum creatinine due to

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

There are no references for this article.